FindTrial
Sign In

Individualized induced pluripotent stem cells from the fibroblasts of patients’ lesions with different skin diseases

Individualized induced pluripotent stem cells from the fibroblasts of patients’ lesions with different skin diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-17011649
Enrollment
Unknown
Registered
2017-06-13
Start date
2017-06-20
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keloid, psoriasis, skin malignant tumo

Interventions

Healthy group:Take the skin
vitiligo group:Take the skin
Keloid group:Take the skin
skin malignant tumor:Take the skin

Sponsors

Department of Dermatology, Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: suffering from keloids, vitiligo, psoriasis, skin cancer patients need surgery

Exclusion criteria

Exclusion criteria: 1. Obvious signs and signs of infection, or laboratory tests without evidence of infection 2. Immunosuppressive drugs such as systemic immune function were used in the month before treatment 3. Dermatitis, psoriasis, rheumatoid arthritis and other autoimmune diseases and other allergic diseases

Design outcomes

Primary

MeasureTime frame
Age;Disease type;—

Countries

China

Contacts

Public ContactLI Yumei

Jiangsu University

l.yumei@aliyun.com+86 13914569541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026